We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
45 hedge funds and large institutions have $475M invested in Jade Biosciences in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more capital invested
Capital invested by funds: $302M → $475M (+$174M)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
0.04% more ownership
Funds ownership: 2.99% → 3.04% (+0.04%)
4% less funds holding
Funds holding: 47 → 45 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
0.71%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
9
Increased
15
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.64M |
| 2 |
VA
VR Adviser
New York
|
+$1.67M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.11M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$743K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$415K |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$1.2M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$708K |
| 3 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$438K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$424K |
| 5 |
HF
HRT Financial
New York
|
-$410K |
